The duration of treatment depends on your weight loss goals
Crafted with the needs of GLP-1 users in mind, it delivers refined and targeted support for the most common challenges experienced during treatment, including low energy, reduced mood, muscle loss, dehydration, constipation, hair thinning, changes in skin quality and reduced intake of essential proteins, vitamins and minerals
Patients with chronic hyperglycemia may have a significant negative effect on bone mass
They are usually compared based on research focus rather than a strict better-or-worse hierarchy
The medication is still available, but the original Saxenda brand from Novo Nordisk has had long-term supply problems and is being phased out
Oral GLP-1 vs